Caplight Directory>Companies>F2g-preview>F2g


F2g

F2g

Private
Manchester, EnglandHealthcare & Life Scienceshttps://www.f2g.com

Last Round

Series H

Sep 12, 2024

Total Funding Raised

$293.45M

Momentum Score

50 /100

Company Overview

F2G is a biotechnology company focused on developing innovative therapies for life-threatening fungal infections.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

antifungal drugOlorofimorotomidesinvasive fungal infectionsfirst-in-class antifungalantifungal resistanceDHODH inhibitorbiotechdrug developmentclinical-stage biopharmasmall-molecule drugrare fungal infectionsBreakthrough Therapy designationorphan drug designationinvasive aspergillosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

F2g Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

F2g Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series HSep 12, 2024
VC RoundAug 4, 2022
Series FAug 12, 2020
VC RoundJan 7, 2019
DebtNov 22, 2018
Series E
Jun 20, 2016
View all Funding Rounds

F2g Investors

Notable investors and investment history

InvestorRounds
Heartcore CapitalSeries D, Series E
Owl Rock Capital GroupSeries H
AMR Action FundSeries H
Brace Pharma CapitalSeries E, Series F
BankInvestSeries A
Intermediate Capital GroupSeries H
Morningside VenturesSeries H, Series F, VC Round
View all Investors

F2g Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

F2g Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about F2g's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester, England
Employee Range95
Year Founded1998
Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.